{
    "clinical_study": {
        "@rank": "120958", 
        "acronym": "3D", 
        "arm_group": {
            "arm_group_label": "myometrial fibroid/adenomyoma", 
            "arm_group_type": "Experimental", 
            "description": "Patients scheduled for myomectomy or hysterectomy with  preoperative diagnosis of uterine myoma, adenomyosis or both  by  ultrasound .Trans-vaginal 3D power Doppler and uterine artery doppler  will be done for all participants prior to surgery."
        }, 
        "brief_summary": {
            "textblock": "Colour Doppler sonography has also been evaluated in differentiating adenomyosis from\n      fibroids. Two dimensional color Doppler ultrasound revealed that 87% of adenomyosis cases\n      had vessel distributions different from those found in leiomyoma cases, in addition to a\n      high pulsatility index (PI) .Adenomyotic lesions had  randomly scattered vessels or\n      intratumoral signals while leiomyomas usually had peripheral scattered or outer feeding\n      vessels."
        }, 
        "brief_title": "The Use of Doppler to Diagnose Myometrial Masses", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Uterine Masses", 
        "detailed_description": {
            "textblock": "Because it is more sensitive, less angle-dependent, and not susceptible to aliasing , power\n      Doppler Sonography has the potential to detect fluctuations in blood flow , with results\n      superior to those of frequency-based color Doppler sonography, particularly in situations of\n      low-velocity blood flow. Three dimensional power Doppler ultrasonography can be applied to\n      differentiate  between uterine adenomyosis and leiomyoma ,and it may reduce the number of\n      false positives by detailed investigations."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 20 & 60 years.\n\n          -  Asymptomatic pts which discover the mass accidentally .\n\n          -  Patients with symptoms like menorrhagia, menometrorrhagia, dysmenorrheal ,\n             abdominal masses.\n\n          -  Patients scheduled for hysterectomy(abdominal/vaginal or Laparoscopic)\n\n          -  Patients scheduled for myomectomy.\n\n        Exclusion Criteria:\n\n          -  Pregnant patients\n\n          -  Age over 60 or under 20years.\n\n          -  Conservative management (Non surgical)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01833871", 
            "org_study_id": "Protocol200"
        }, 
        "intervention": [
            {
                "arm_group_label": "myometrial fibroid/adenomyoma", 
                "description": "Trans-vaginal 3D power Doppler Ultrasonographic examination will be done for all participants prior to surgery. The ultrasonographic examination will provide data related to lesion size, lesion volume, vascular location (location), vascular index (VI), flow index (FI), and vascular-flow index (VFI). The region of interest will include the entire region of the uterine mass. The virtual organ computer aided analysis (VOCAL) software for the analysis of 3D power Doppler histograms will be used with computer algorithms to form indices of blood flow and vascularization. All data will be collected and compared with the post operative histopathology results.", 
                "intervention_name": "Three dimensional Power Doppler to the myometrial mass", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "myometrial fibroid/adenomyoma", 
                "description": "uterine artery Doppler indices(RI,PI) are measured for all cases with myometrial mass", 
                "intervention_name": "Uterine artery Doppler", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt"
                }, 
                "name": "Cairo University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "1", 
        "official_title": "Uterine Artery Doppler and Three Dimensional Power Doppler in the Diagnosis of Myometrial Masses", 
        "overall_contact": {
            "email": "emyelkattan@gmail.com", 
            "last_name": "Eman A. Elkattan, M.D,MRCOG", 
            "phone": "00201222854159"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The ultrasonographic examination will provide data related to lesion size, lesion volume, uterine artery doppler indices and vascular location (location), vascular index (VI), flow index (FI), and vascular-flow index (VFI). The region of interest will include the entire region of the uterine mass. The virtual organ computer aided analysis (VOCAL) software for the analysis of 3D power Doppler histograms will be used with computer algorithms to form indices of blood flow and vascularization. All data will be collected and compared with the post operative histopathology results.", 
                "measure": "Power Doppler Vascular indices", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "description": "Uterine artery doppler indices(RI,PI) in fibroids in relation to adenomyosis", 
                "measure": "Uterine artery doppler indices in fibroids in relation to adenomyosis", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01833871"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cairo University", 
            "investigator_full_name": "Eman Elkattan", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Cairo University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cairo University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}